Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Subject Area // Chemotherapy
Researchers from New York University Abu Dhabi (Abu Dhabu, UAE) have developed novel hybrid nanocarriers that could be loaded with multiple chemotherapeutics for the safe targeting of cancer cells.
Testing the nanocarrier in tumor-bearing mice demonstrated a reduction in tumor volume and prolonged survival, with no adverse side effects.
Read the full news story on our sister site, Nanomed Zone, here.
Written ByHeather Jones, Future Science Group